Cost Guide · 2026
Retatrutide Cost with Cash Pay: 2026 Pricing
Retatrutide is an investigational medication, and is not commercially available with insurance coverage as it has not received FDA approval yet. This guide covers everything you need to know about Retatrutide pricing in 2026.
⚠️ Medical Disclaimer
This page is for educational purposes only and does not constitute medical advice. GLP-1 medications are prescription drugs. Discuss all treatment decisions with a licensed healthcare provider who knows your complete medical history. Individual results vary significantly from clinical trial averages.
List Price
Not yet commercially available
With Insurance
N/A
Prior Auth
Not applicable (investigational)
Retatrutide + Cash Pay: What to Expect
Cash-pay patients typically pay list price or slightly below via manufacturer discount programs. Manufacturer savings cards (Eli Lilly's Zepbound Savings Card, Novo Nordisk's NovoCare program) can significantly reduce costs for eligible patients without government insurance.
Price Breakdown by Coverage Type
| Coverage Type | Typical Monthly Cost | Notes |
|---|---|---|
| List price (cash) | Not yet commercially available | Without any coverage or discount |
| Commercial insurance | N/A | Highly variable by plan and formulary tier |
| Manufacturer savings card | Not available (investigational) | N/A |
| Compounded | Not available | Not available — investigational drug |
Prior Authorization Requirements
Prior authorization (PA) is not applicable for this medication at this time. The PA process typically requires:
- Diagnosis of obesity (BMI ≥30) or overweight (BMI ≥27) with at least one weight-related comorbidity
- Documentation of previous lifestyle modification attempts
- Sometimes: failure of prior obesity pharmacotherapy (step therapy)
- Sometimes: specific HbA1c criteria for diabetic indications
Prior authorization approval rates vary significantly by payer. Your prescriber's office can assist with the PA process.
Manufacturer Savings Programs
No manufacturer savings programs are available for investigational medications outside of clinical trials.
Cost-Reduction Strategies
- GoodRx: Compare pharmacy prices — variation of $50–$150/month between pharmacies is common
- 90-day supply: Many pharmacies and mail-order programs offer 10–20% savings on 90-day fills
- Patient assistance programs: Income-based programs may provide the medication at low or no cost for qualifying patients
- HSA/FSA funds: Pre-tax dollars can be used for prescription costs — effectively reducing cost by your marginal tax rate
- Clinical trials: Eligible patients may receive medication at no cost through clinical trial participation — see ClinicalTrials.gov
Retatrutide 2026 Cost Outlook
GLP-1 medication pricing continues to evolve. Key factors affecting Retatrutide costs in 2026 include: its pending FDA approval status — commercial availability and pricing will be established post-approval (projected 2027–2028 for some agents in this class).
💰 Cost Estimator Calculator
Enter your specific insurance details to get a personalized cost estimate for Retatrutide and alternatives.
Open Cost Estimator →